MPN-377: Updated Results from a Phase 1/2 Clinical Trial of Tagraxofusp, a CD123-Targeted Therapy, in Patients with Poor-Risk Myelofibrosis

Clinical Lymphoma Myeloma and Leukemia(2020)

引用 0|浏览0
暂无评分
关键词
MF,myelofibrosis,tagraxofusp,TAG,novel therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要